Has there been a shift in how the European courts approach preliminary injunctions?
by Dr Paul England and Christoph de Coster, LL.M. (UC Davis)
AI driven drug design
Unpacking the role of AI in bringing new drugs to market.
1 of 6 Insights
The EU torpedoes itself in cross-border patent disputes
Paul England and Simon Cohen launch new life sciences IP guide
by Dr Paul England and Simon Cohen
Acting on transformational roll-up and $250 million crossover financing of cutting-edge UK and European biotech companies
by multiple authors
Edison Open House Global Healthcare 2021 – key takeaways from our panel
by multiple authors
Will the UK government's COVID-19 dosing regime gamble pay off?
by Alison Dennis and Justyna Ostrowska
What the UK-EU Trade and Cooperation Agreement means for pharma and medical device companies
8+2+1 plus what? How UK data and market exclusivity rights will be affected from 1 January 2021
by Alison Dennis and Dr Paul England
